The Centers for Medicare & Medicaid Services is approving some 2022 MIPS targeted review requests made by retina groups who were inappropriately scored on the diabetes episode-based cost measure.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.